Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 16237722)

Published in J Neurosci Res on November 15, 2005

Authors

Martin Wirenfeldt1, Alicia Anne Babcock, Rune Ladeby, Kate Lykke Lambertsen, Frederik Dagnaes-Hansen, Robert Graham Quinton Leslie, Trevor Owens, Bente Finsen

Author Affiliations

1: Medical Biotechnology Center, University of Southern Denmark, Odense. mwnielsen@health.sdu.dk

Articles citing this

Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res (2006) 1.91

B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A (2008) 1.37

Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia (2006) 1.33

Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS One (2007) 1.33

Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol (2007) 1.31

Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J Virol (2007) 1.24

Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis. Neurobiol Dis (2008) 1.16

Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Methods (2007) 1.05

Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus. J Neurosci (2015) 1.00

Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinflammation (2012) 0.96

Population control of resident and immigrant microglia by mitosis and apoptosis. Am J Pathol (2007) 0.92

Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism. Neurobiol Dis (2011) 0.90

Age-dependent microglial activation in immature brains after hypoxia- ischemia. CNS Neurol Disord Drug Targets (2013) 0.89

Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J (2012) 0.82

Articles by these authors

Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol (2008) 3.75

Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci (2003) 2.52

Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab (2012) 2.25

Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci (2009) 1.97

Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation (2008) 1.92

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes (2002) 1.67

Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev (2005) 1.67

Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci (2006) 1.49

A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol (2008) 1.40

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts. Cancer Res (2009) 1.39

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest (2003) 1.37

The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice. Mol Ther (2009) 1.35

IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J (2008) 1.34

Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol (2004) 1.32

The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke (2009) 1.32

Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol (2007) 1.31

Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.30

TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest (2012) 1.24

Statin therapy inhibits remyelination in the central nervous system. Am J Pathol (2009) 1.23

A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol (2004) 1.21

A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2005) 1.18

Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system. J Immunol (2006) 1.17

Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. Endocrinology (2007) 1.16

Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia (2011) 1.11

Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol (2010) 1.10

Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia. J Biol Chem (2001) 1.10

Dynamics of microglia in the developing rat brain. J Comp Neurol (2003) 1.09

Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis (2009) 1.09

Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia (2012) 1.09

Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am J Pathol (2006) 1.09

A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep (2013) 1.07

Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia (2013) 1.06

Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia (2005) 1.06

Glyceraldehyde-3-phosphate dehydrogenase versus toluidine blue as a marker for infarct volume estimation following permanent middle cerebral artery occlusion in mice. Exp Brain Res (2006) 1.05

Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol (2005) 1.05

Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab (2002) 1.05

Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning. J Biol Chem (2010) 1.03

CD8+ T cells in inflammatory demyelinating disease. J Neuroimmunol (2007) 1.03

Unbiased cell quantification reveals a continued increase in the number of neocortical neurones during early post-natal development in mice. Eur J Neurosci (2007) 1.02

Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur J Immunol (2004) 1.01

What is microglia neurotoxicity (Not)? Glia (2014) 0.99

Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol (2007) 0.98

Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J Neurochem (2007) 0.98

Interferons in the central nervous system: a few instruments play many tunes. Glia (2014) 0.97

Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment. Immunology (2009) 0.97

Fkbp8: novel isoforms, genomic organization, and characterization of a forebrain promoter in transgenic mice. Genomics (2004) 0.96

Complement's participation in acquired immunity. J Leukoc Biol (2002) 0.96

Toll-like receptors in brain development and homeostasis. Sci STKE (2007) 0.96

Differences in origin of reactive microglia in bone marrow chimeric mouse and rat after transient global ischemia. J Neuropathol Exp Neurol (2011) 0.96

IFN-gamma-induced chemokines synergize with pertussis toxin to promote T cell entry to the central nervous system. J Immunol (2007) 0.95

Validation of two reference genes for mRNA level studies of murine disease models in neurobiology. J Neurosci Methods (2006) 0.95

Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer's disease. Aging Cell (2014) 0.94

NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol (2008) 0.94

Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid. J Neuroimmunol (2012) 0.93

Signaling through MyD88 regulates leukocyte recruitment after brain injury. J Immunol (2008) 0.93

Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex. J Histochem Cytochem (2007) 0.93

Population control of resident and immigrant microglia by mitosis and apoptosis. Am J Pathol (2007) 0.92

Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol (2015) 0.91

Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death. Cancer Res (2006) 0.91

Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration. Oligonucleotides (2009) 0.91

Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem (2013) 0.91

CSF transthyretin neuroprotection in a mouse model of brain ischemia. J Neurochem (2010) 0.90

Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA. J Gene Med (2012) 0.90

Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein. J Immunol (2010) 0.90

Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model. J Neuroimmune Pharmacol (2013) 0.89

Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse. Glia (2006) 0.89

Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain. Eur J Neurosci (2006) 0.88

Innate immune responses in central nervous system inflammation. FEBS Lett (2011) 0.88

Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation. Fluids Barriers CNS (2012) 0.88

Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Immunology (2006) 0.88

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. Prostate (2003) 0.88

The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover. Arthritis Res Ther (2009) 0.87

Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J (2003) 0.87

Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J Neuroinflammation (2011) 0.86

Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokine-chemokine-cytokine-chemokine cascade. J Immunol (2009) 0.86

Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease. PLoS One (2011) 0.86

Neuromyelitis optica-like pathology is dependent on type I interferon response. Exp Neurol (2013) 0.85

Immunohistochemical visualization of neurons and specific glial cells for stereological application in the porcine neocortex. J Neurosci Methods (2005) 0.85

A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease. J Immunol (2006) 0.85

Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation. J Neuroimmunol (2008) 0.84

Estimation of absolute microglial cell numbers in mouse fascia dentata using unbiased and efficient stereological cell counting principles. Glia (2003) 0.84

The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells. Eur J Immunol (2002) 0.84

Efficacy of transgene expression in porcine skin as a function of electrode choice. Bioelectrochemistry (2011) 0.83

Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo. J Gene Med (2012) 0.83